As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers.
The post Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? appeared first on MedCity News.
